{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:23:55Z","timestamp":1791343435509,"version":"4.3.1"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"1072","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":2920,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population in many developed countries. Between 10% and 30% of patients with NAFLD have non-alcoholic steatohepatitis (NASH) that can progress to cirrhosis. There are metabolic risk factors common to both NAFLD and cardiovascular disease, so patients with NASH have an increased risk of liver-related and cardiovascular death. Management of patients with NAFLD depends largely on the stage of disease, emphasising the importance of careful risk stratification. There are four main areas to focus on when thinking about management strategies in NAFLD: lifestyle modification, targeting the components of the metabolic syndrome, liver-directed pharmacotherapy for high risk patients and managing the complications of cirrhosis.<\/jats:p>","DOI":"10.1136\/postgradmedj-2013-100404rep","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T13:50:54Z","timestamp":1423144254000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Republished: Non-alcoholic fatty liver disease: a practical approach to treatment"],"prefix":"10.1093","volume":"91","author":[{"given":"J K","family":"Dyson","sequence":"first","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q M","family":"Anstee","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne, UK"},{"name":"Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"McPherson","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne, UK"},{"name":"Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"2023041905284419400_R1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"2023041905284419400_R2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"2023041905284419400_R3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"2023041905284419400_R4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Non alcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"2023041905284419400_R6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"2023041905284419400_R8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2023041905284419400_R9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"2023041905284419400_R10","doi-asserted-by":"crossref","first-page":"d3897","DOI":"10.1136\/bmj.d3897","article-title":"How big a problem is non-alcoholic fatty liver disease?","volume":"343","author":"Anstee","year":"2011","journal-title":"BMJ"},{"key":"2023041905284419400_R11","article-title":"NICE Clinical guidelines. CG43 Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children","author":"NICE","year":"2006"},{"key":"2023041905284419400_R12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"2023041905284419400_R13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"2023041905284419400_R14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/dc06-2032","article-title":"Habitual physical activity is associated with intrahepatic fat content in humans","volume":"30","author":"Perseghin","year":"2007","journal-title":"Diabetes Care"},{"key":"2023041905284419400_R15","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1152\/ajpendo.00210.2009","article-title":"Effects of 7\u2005days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus","volume":"297","author":"Kirwan","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023041905284419400_R16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1249\/MSS.0b013e3181df16d9","article-title":"Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth","volume":"42","author":"Van Der Heijden","year":"2010","journal-title":"Med Sci Sport Exerc"},{"key":"2023041905284419400_R17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J Hepatol"},{"key":"2023041905284419400_R18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss","volume":"60","author":"Hallsworth","year":"2011","journal-title":"Gut"},{"key":"2023041905284419400_R19","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023041905284419400_R20","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10\u2005years after bariatric surgery","volume":"351","author":"Sjostrom","year":"2004","journal-title":"NEJM"},{"key":"2023041905284419400_R21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"NEJM"},{"key":"2023041905284419400_R23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2036.2011.04912.x","article-title":"Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis","volume":"35","author":"Boettcher","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905284419400_R24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"2023041905284419400_R25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","article-title":"Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease","volume":"86","author":"Zivkovic","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2023041905284419400_R26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3945\/ajcn.2008.26720","article-title":"Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver","volume":"89","author":"Musso","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"2023041905284419400_R27","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2023041905284419400_R28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol"},{"key":"2023041905284419400_R29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"2023041905284419400_R30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J Hepatol"},{"key":"2023041905284419400_R31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease","volume":"137","author":"Mathurin","year":"2009","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R32","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.22525","article-title":"Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study","volume":"48","author":"Zelber-Sagi","year":"2008","journal-title":"Hepatology"},{"key":"2023041905284419400_R33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.97.7.661","article-title":"Regular physical activity and coronary risk factors in Japanese men","volume":"97","author":"Hsieh","year":"1998","journal-title":"Circulation"},{"key":"2023041905284419400_R34","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1152\/japplphysiol.00921.2011","article-title":"Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes","volume":"111","author":"Little","year":"2011","journal-title":"J Appl Physiol"},{"key":"2023041905284419400_R35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2006.02.004","article-title":"A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease","volume":"4","author":"Zelber-Sagi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023041905284419400_R36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"NEJM"},{"key":"2023041905284419400_R37","first-page":"CD007340","article-title":"Bariatric surgery for non-alcoholic steatohepatitis in obese patients","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database System Rev"},{"key":"2023041905284419400_R38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.21472","article-title":"Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery","volume":"14","author":"D'Albuquerque","year":"2008","journal-title":"Liver Transpl"},{"key":"2023041905284419400_R39","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023041905284419400_R40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2012.07.021","article-title":"Bariatric surgery in patients with liver cirrhosis","volume":"9","author":"Shimizu","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"2023041905284419400_R41","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"NEJM"},{"key":"2023041905284419400_R42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"2023041905284419400_R43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2337\/dc10-2412","article-title":"Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting","volume":"34","author":"Piccinni","year":"2011","journal-title":"Diabetes Care"},{"key":"2023041905284419400_R44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","article-title":"Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis","volume":"8","author":"Lecka-Czernik","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"2023041905284419400_R45","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"2023041905284419400_R46","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"2023041905284419400_R48","doi-asserted-by":"crossref","first-page":"c5702","DOI":"10.1136\/bmj.c5702","article-title":"Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials","volume":"341","author":"Schurks","year":"2010","journal-title":"BMJ"},{"key":"2023041905284419400_R49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"key":"2023041905284419400_R50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"2023041905284419400_R51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MEG.0b013e32835d72cf","article-title":"Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?","volume":"25","author":"McPherson","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023041905284419400_R52","article-title":"NICE clinical guidelines","volume-title":"CG87 Type 2 diabetes: The management of type 2 diabetes","author":"NICE","year":"2010"},{"key":"2023041905284419400_R53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"2023041905284419400_R54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2023041905284419400_R55","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc12-2504","article-title":"A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks","volume":"36","author":"Nauck","year":"2013","journal-title":"Diabetes Care"},{"key":"2023041905284419400_R56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.12149","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program","volume":"37","author":"Armstrong","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905284419400_R57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03345423","article-title":"Does use of metformin protect against cancer in Type 2 diabetes mellitus?","volume":"35","author":"Bo","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2023041905284419400_R58","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gutjnl-2011-301708","article-title":"Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies","volume":"62","author":"Chen","year":"2013","journal-title":"Gut"},{"key":"2023041905284419400_R59","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"2023041905284419400_R60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R61","article-title":"NICE clinical guidelines","volume-title":"CG127 Hypertension: Clinical management of primary hypertension in adults","author":"NICE","year":"2011"},{"key":"2023041905284419400_R62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v4.i12.327","article-title":"Nonalcoholic fatty liver disease and the renin-angiotensin system: implications for treatment","volume":"4","author":"Paschos","year":"2012","journal-title":"World J Hepatol"},{"key":"2023041905284419400_R64","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2023041905284419400_R65","first-page":"448","article-title":"Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis","volume":"17","author":"Al-Mallah","year":"2010","journal-title":"Cardiology J"},{"key":"2023041905284419400_R66","article-title":"NICE. NICE clinical guidelines","volume-title":"CG67 Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease","year":"2010"},{"key":"2023041905284419400_R67","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"2023041905284419400_R68","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"2023041905284419400_R69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: a Systematic Review and Meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"key":"2023041905284419400_R71","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ALN.0b013e31816d83e4","article-title":"STOP questionnaire: a tool to screen patients for obstructive sleep apnea","volume":"108","author":"Chung","year":"2008","journal-title":"Anesthesiology"},{"key":"2023041905284419400_R72","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"2023041905284419400_R73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"2023041905284419400_R74","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer","year":"2012","journal-title":"J Hepatol"},{"key":"2023041905284419400_R75","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0168-8278(03)00349-0","article-title":"Screening for hepatocellular carcinoma in cirrhosis","volume":"39","author":"Bolondi","year":"2003","journal-title":"J Hepatol"},{"key":"2023041905284419400_R76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7863\/jum.2001.20.2.99","article-title":"Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients","volume":"20","author":"Kim","year":"2001","journal-title":"J Ultrasound Med"},{"key":"2023041905284419400_R77","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-009-0112-0","article-title":"Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis","volume":"44","author":"Kawada","year":"2009","journal-title":"J Gastroenterol"},{"key":"2023041905284419400_R78","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"NEJM"},{"key":"2023041905284419400_R79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","article-title":"Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women","volume":"101","author":"Gunter","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2023041905284419400_R80","doi-asserted-by":"crossref","first-page":"s836","DOI":"10.1093\/ajcn\/86.3.836S","article-title":"Metabolic syndrome, hyperinsulinemia, and colon cancer: a review","volume":"86","author":"Giovannucci","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2023041905284419400_R81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-540-69297-3_5","article-title":"Energy metabolism, cancer risk, and cancer prevention","volume":"181","author":"Pollak","year":"2009","journal-title":"Recent Results Cancer Res"},{"key":"2023041905284419400_R82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10059-013-0169-8","article-title":"Metabolic roles of AMPK and metformin in cancer cells","volume":"36","author":"Choi","year":"2013","journal-title":"Mol Cells"},{"key":"2023041905284419400_R83","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2023041905284419400_R84","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3748\/wjg.15.2506","article-title":"Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease","volume":"5","author":"Donadon","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2023041905284419400_R85","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"key":"2023041905284419400_R86","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","article-title":"Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes","volume":"136","author":"El-Serag","year":"2009","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R87","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ajg.2010.475","article-title":"Statin use and the risk of liver cancer: a population-based case-control study","volume":"106","author":"Chiu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2023041905284419400_R88","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2023041905284419400_R89","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res"},{"key":"2023041905284419400_R90","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","article-title":"MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer","volume":"431","author":"Shachaf","year":"2004","journal-title":"Nature"},{"key":"2023041905284419400_R91","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1158\/0008-5472.CAN-10-3367","article-title":"MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res"},{"key":"2023041905284419400_R92","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/archinte.161.21.2564","article-title":"Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage","volume":"161","author":"Zaman","year":"2001","journal-title":"Arch Intern Med"},{"key":"2023041905284419400_R93","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"(Suppl 3\u20134)","key":"2023041905284419400_R94","first-page":"III1","article-title":"UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology","volume":"46","author":"Jalan","year":"2000","journal-title":"Gut"},{"issue":"(Suppl 1)","key":"2023041905284419400_R95","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"},{"key":"2023041905284419400_R96","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"2023041905284419400_R97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"2023041905284419400_R98","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lt.21943","article-title":"Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis","volume":"15","author":"Malik","year":"2009","journal-title":"Liver Transpl"},{"key":"2023041905284419400_R99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transpl"},{"key":"2023041905284419400_R100","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/gutjnl-2011-300886","article-title":"Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis","volume":"61","author":"Newsome","year":"2012","journal-title":"Gut"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/91\/1072\/92\/49960020\/postgradmedj-91-92.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/91\/1072\/92\/49960020\/postgradmedj-91-92.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T05:32:03Z","timestamp":1681882323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/91\/1072\/92\/6993895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":100,"journal-issue":{"issue":"1072","published-online":{"date-parts":[[2015,2,5]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2013-100404rep","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2,1]]}}}